(Q36577179)

15 August 2017

A serum potassium level above 10 mmol/l in a patient predisposed to hypokalemia (English)

1 reference

15 August 2017

David R Phillips

1

1 reference

15 August 2017

Kashif I Ahmad

2

1 reference

15 August 2017

Sarah J Waller

3

1 reference

15 August 2017

Peter Meisner

4

1 reference

15 August 2017

Fiona E Karet

5

1 reference

15 August 2017

1 June 2006

1 reference

Nature Clinical Practice Nephrology

15 August 2017

1 reference

15 August 2017

2

1 reference

15 August 2017

6

1 reference

15 August 2017

340-6; quiz 347

1 reference

Salt handling in the distal nephron: lessons learned from inherited human disorders.

15 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0201

Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0201

7 January 2021

Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0201

7 January 2021

Functional expression of mutations in the human NaCl cotransporter: evidence for impaired routing mechanisms in Gitelman's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0201

7 January 2021

Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0201

7 January 2021

Magnesium supplementation in Gitelman syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0201

7 January 2021

Non-steroidal anti-inflammatory drug-associated nephrotoxicity in Bartter syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0201

7 January 2021

Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0201

7 January 2021

Correction of hypokalemia with antialdosterone therapy in Gitelman's syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0201

7 January 2021

Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0201

7 January 2021

Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0201

7 January 2021

Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0201

7 January 2021

Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0201

7 January 2021

Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0201

7 January 2021

Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0201

7 January 2021

Association between activating mutations of calcium-sensing receptor and Bartter's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0201

7 January 2021

Identifiers

DOI

10.1038/NCPNEPH0201

1 reference

15 August 2017

1 reference